Sitagliptin/Metformin Krka

Sitagliptin/Metformin Krka combines two diabetes medications to improve blood sugar control. This oral tablet is prescribed for type 2 diabetes management alongside diet and exercise. It belongs to the DPP-4 inhibitor and biguanide classes. Suitable for adults with diabetes.

Sitagliptin/Metformin Krka is used to treat type 2 diabetes in adults. It helps lower blood sugar levels by increasing insulin production and reducing glucose production in the liver. This combination therapy is typically prescribed when diet and exercise alone are insufficient. It may also be used with other diabetes medications.

This medication helps maintain steady blood sugar levels throughout the day. Users may notice improved energy levels and reduced symptoms like excessive thirst or frequent urination. Some people experience mild digestive changes when starting treatment. Effects vary by individual and may take several weeks to become noticeable.

Store Sitagliptin/Metformin Krka at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or the tablets show signs of deterioration. Inform your healthcare provider about all medications and supplements you take before starting this treatment.

Sitagliptin/Metformin Krka may interact with alcohol, increasing the risk of lactic acidosis. Certain medications like diuretics or corticosteroids can affect blood sugar levels. Inform your doctor if you take drugs for high blood pressure, heart conditions, or other diabetes medications. Regular monitoring may be required when combining therapies.